Please note: AABB reserves the right to make updates to this program.
Live Program: Tuesday, March 20, 2018 -
Master Program Number: 18EL-322 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Managers/Supervisors, Medical Director, Nurses, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologist, Transfusion Safety Officer
Teaching Level: Basic to Intermediate
Moderator: Mark Fung, MD, PhD, University of Vermont Medical Center, Burlington, VT
Presenters: Sarah Vossoughi, MD, Clinical Pathology Chief Resident, Columbia University Medical Center, New York, NY; Kathryn Haass, BB(ASCP), MPH, Health Research Analyst, CDC, Atlanta, GA; Srijana Rajbhandary, MPH, Research and Data Analyst, Department of Research, AABB, Bethesda, MD
After participating in this educational activity, participants should be able to:
- Demonstrate the use of the CDC NHSN Hemovigilance Module.
- Define hemovigilance and explain its use and impact in the practice of transfusion medicine.
- Recognize how hemovigilance benchmarking can be used to improve patient safety.
- Contrast transfusion reactions in the pediatric populations with those of the adult population.
This program is designed to provide an introduction to hemovigilance. The history of hemovigilance, what's new in the US CDC National Healthcare Safety Network (NHSN) Hemovigilance Modules, and the ongoing benefits of participation will be discussed. A live demonstration of the CDC National Healthcare Safety Network Hemovigilance Module will allow users to visualize the hemovigilance experience. Instructions for how to get started using hemovigilance definitions, how to enter data into the CDC NHSN Hemovigilance Module, and how to join the AABB Center for Patient Safety will be explained. The use of pediatric hemovigilance data will be discussed in the context of patient safety.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||